探索与自然致幻剂使用后神秘体验强度相关的因素:回顾性调查。

IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY
B. Romeo , E. Kervadec , B. Fauvel , L. Strika-Bruneau , A. Amirouche , V. Verroust , P. Piolino , A. Benyamina
{"title":"探索与自然致幻剂使用后神秘体验强度相关的因素:回顾性调查。","authors":"B. Romeo ,&nbsp;E. Kervadec ,&nbsp;B. Fauvel ,&nbsp;L. Strika-Bruneau ,&nbsp;A. Amirouche ,&nbsp;V. Verroust ,&nbsp;P. Piolino ,&nbsp;A. Benyamina","doi":"10.1016/j.pnpbp.2025.111300","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The intensity of the psychedelic experience has been hypothesized as the main predictor of response to a psychedelic treatment. This study aimed to investigate factors that may be associated with the intensity of mystical experiences during naturalistic psychedelic use.</div></div><div><h3>Methods</h3><div>The data of this comprehensive sample were aggregated from four previous retrospective surveys, where mystical experience intensity was assessed using the mystical experience questionnaire (MEQ-30). Additional collected data included psychological flexibility levels, intentions regarding psychedelic use, substance used, subjective dosage levels, and socio-demographic information. ANOVA and linear regression were performed to identify predictors of MEQ-30 scores.</div></div><div><h3>Results</h3><div>A total of 1657 participants were included in this study. The significant predictors of the total MEQ score were: the main motive for the psychedelic experience (with a greater impact of spiritual/religious, therapeutic, and self-exploration, compared to recreational), the type of substance used (with a greater impact for Ayahuasca and lysergic acid diethylamide than for psilocybin), the subjective dosage (greater impact of very high, high, and moderate doses, compared to a very low dose), the number of psychedelic sessions, the time elapsed since the experience, and concomitant alcohol use.</div></div><div><h3>Conclusion</h3><div>This large sample study highlights significant associations between the intensity of mystical experiences during naturalistic psychedelic use and several key factors: the type of the psychedelic substance used, dosage, and set, particularly participants' intentions. Moreover, results show that concomitant alcohol use is associated with less intense psychedelic experiences, emphasizing the relevance of screening participants for substance use in research settings.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"137 ","pages":"Article 111300"},"PeriodicalIF":5.3000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey\",\"authors\":\"B. Romeo ,&nbsp;E. Kervadec ,&nbsp;B. Fauvel ,&nbsp;L. Strika-Bruneau ,&nbsp;A. Amirouche ,&nbsp;V. Verroust ,&nbsp;P. Piolino ,&nbsp;A. Benyamina\",\"doi\":\"10.1016/j.pnpbp.2025.111300\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>The intensity of the psychedelic experience has been hypothesized as the main predictor of response to a psychedelic treatment. This study aimed to investigate factors that may be associated with the intensity of mystical experiences during naturalistic psychedelic use.</div></div><div><h3>Methods</h3><div>The data of this comprehensive sample were aggregated from four previous retrospective surveys, where mystical experience intensity was assessed using the mystical experience questionnaire (MEQ-30). Additional collected data included psychological flexibility levels, intentions regarding psychedelic use, substance used, subjective dosage levels, and socio-demographic information. ANOVA and linear regression were performed to identify predictors of MEQ-30 scores.</div></div><div><h3>Results</h3><div>A total of 1657 participants were included in this study. The significant predictors of the total MEQ score were: the main motive for the psychedelic experience (with a greater impact of spiritual/religious, therapeutic, and self-exploration, compared to recreational), the type of substance used (with a greater impact for Ayahuasca and lysergic acid diethylamide than for psilocybin), the subjective dosage (greater impact of very high, high, and moderate doses, compared to a very low dose), the number of psychedelic sessions, the time elapsed since the experience, and concomitant alcohol use.</div></div><div><h3>Conclusion</h3><div>This large sample study highlights significant associations between the intensity of mystical experiences during naturalistic psychedelic use and several key factors: the type of the psychedelic substance used, dosage, and set, particularly participants' intentions. Moreover, results show that concomitant alcohol use is associated with less intense psychedelic experiences, emphasizing the relevance of screening participants for substance use in research settings.</div></div>\",\"PeriodicalId\":54549,\"journal\":{\"name\":\"Progress in Neuro-Psychopharmacology & Biological Psychiatry\",\"volume\":\"137 \",\"pages\":\"Article 111300\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-02-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neuro-Psychopharmacology & Biological Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0278584625000545\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584625000545","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言:迷幻体验的强度被假设为对迷幻治疗反应的主要预测因子。本研究旨在探讨在自然致幻剂使用过程中可能与神秘体验强度相关的因素。方法:这一综合样本的数据是从以前的四次回顾性调查中汇总的,其中神秘体验强度使用神秘体验问卷(MEQ-30)进行评估。其他收集的数据包括心理灵活性水平、使用致幻剂的意图、使用的物质、主观剂量水平和社会人口信息。采用方差分析和线性回归来确定MEQ-30评分的预测因子。结果:本研究共纳入1657名受试者。MEQ总分的显著预测因子为:迷幻体验的主要动机(与娱乐相比,精神/宗教、治疗和自我探索的影响更大)、使用的物质类型(死藤水和麦角酸二乙胺的影响比裸盖菇素更大)、主观剂量(与极低剂量相比,非常高、高和中等剂量的影响更大)、迷幻的次数、经历后的时间以及伴随的酒精使用。结论:这一大样本研究强调了自然致幻剂使用过程中神秘体验的强度与几个关键因素之间的显著关联:所用致幻剂的类型、剂量和设置,特别是参与者的意图。此外,研究结果表明,同时饮酒与较不强烈的迷幻体验有关,这强调了在研究环境中筛选物质使用参与者的相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey

Introduction

The intensity of the psychedelic experience has been hypothesized as the main predictor of response to a psychedelic treatment. This study aimed to investigate factors that may be associated with the intensity of mystical experiences during naturalistic psychedelic use.

Methods

The data of this comprehensive sample were aggregated from four previous retrospective surveys, where mystical experience intensity was assessed using the mystical experience questionnaire (MEQ-30). Additional collected data included psychological flexibility levels, intentions regarding psychedelic use, substance used, subjective dosage levels, and socio-demographic information. ANOVA and linear regression were performed to identify predictors of MEQ-30 scores.

Results

A total of 1657 participants were included in this study. The significant predictors of the total MEQ score were: the main motive for the psychedelic experience (with a greater impact of spiritual/religious, therapeutic, and self-exploration, compared to recreational), the type of substance used (with a greater impact for Ayahuasca and lysergic acid diethylamide than for psilocybin), the subjective dosage (greater impact of very high, high, and moderate doses, compared to a very low dose), the number of psychedelic sessions, the time elapsed since the experience, and concomitant alcohol use.

Conclusion

This large sample study highlights significant associations between the intensity of mystical experiences during naturalistic psychedelic use and several key factors: the type of the psychedelic substance used, dosage, and set, particularly participants' intentions. Moreover, results show that concomitant alcohol use is associated with less intense psychedelic experiences, emphasizing the relevance of screening participants for substance use in research settings.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
12.00
自引率
1.80%
发文量
153
审稿时长
56 days
期刊介绍: Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject. Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信